Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Hypertension ; 59(2): 453-8, 2012 Feb.
Article in English | MEDLINE | ID: mdl-22215705

ABSTRACT

Betamethasone is administered to accelerate lung development and improve survival of premature infants but may be associated with hypertension later in life. In a sheep model of fetal programming resulting from exposure at day 80 of gestation to Betamethasone (Beta-exposed), adult sheep at 6 to 9 months or 1.8 years of age have elevated mean arterial pressure (MAP) and attenuated spontaneous baroreflex sensitivity (sBRS) for control of heart rate compared to age-matched controls associated with imbalances in angiotensin (Ang) II vs Ang-(1-7) tone. At 6 weeks of age, evoked BRS is already low in the Beta-exposed animals. In this study, we assessed the potential contribution of the renin-angiotensin system to the impaired sBRS. Female lambs (6 weeks old) with Beta exposure in utero had similar MAP to control lambs (78±2 vs 77±2 mm Hg, n=4-5 per group), but lower sBRS (8±1 vs 16±3 ms/mm Hg; P<0.05) and impaired heart rate variability. Peripheral AT1 receptor blockade using candesartan lowered MAP in both groups (≈10 mm Hg) and improved sBRS and heart rate variability in Beta-exposed lambs to a level similar to control. AT7 receptor blockade by infusion of D-ala Ang-(1-7) (700 ng/kg/min for 45 minutes) reduced sBRS 46%±10% in Beta-exposed vs in control lambs (P<0.15) and increased MAP in both groups (≈6±2 mm Hg). Our data reveal that Beta exposure impairs sBRS and heart rate variability at a time point preceding the elevation in MAP via mechanisms involving an imbalance in the Ang II/Ang-(1-7) ratio consistent with a progressive loss in Ang-(1-7) function.


Subject(s)
Angiotensin I/deficiency , Baroreflex/physiology , Betamethasone/adverse effects , Hypertension/chemically induced , Hypertension/physiopathology , Peptide Fragments/deficiency , Prenatal Exposure Delayed Effects/chemically induced , Prenatal Exposure Delayed Effects/physiopathology , Angiotensin I/drug effects , Angiotensin I/pharmacology , Angiotensin II Type 1 Receptor Blockers/pharmacology , Animals , Animals, Newborn , Baroreflex/drug effects , Benzimidazoles/pharmacology , Betamethasone/pharmacology , Biphenyl Compounds , Blood Pressure/drug effects , Blood Pressure/physiology , Disease Models, Animal , Female , Glucocorticoids/adverse effects , Glucocorticoids/pharmacology , Heart Rate/drug effects , Peptide Fragments/drug effects , Peptide Fragments/pharmacology , Pregnancy , Receptor, Angiotensin, Type 1/drug effects , Sheep , Tetrazoles/pharmacology
2.
Curr Opin Pharmacol ; 11(2): 131-7, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21367658

ABSTRACT

Aging, hypertension, and fetal-programmed cardiovascular disease are associated with a functional deficiency of angiotensin (Ang)-(1-7) in the brain dorsomedial medulla. The resulting unrestrained activity of Ang II in brainstem regions negatively impacts resting mean arterial pressure, sympathovagal balance, and baroreflex sensitivity for control of heart rate. The differential effects of Ang II and Ang-(1-7) may be related to the cellular sources of these peptides as well as different precursor pathways. Long-term alterations of the brain renin-angiotensin system may influence signaling pathways including phosphoinositol-3-kinase and mitogen-activated protein kinase and their downstream mediators, and as a consequence may influence metabolic function. Differential regulation of signaling pathways in aging and hypertension by Ang II versus Ang-(1-7) may contribute to the autonomic dysfunction accompanying these states.


Subject(s)
Angiotensin II/physiology , Angiotensin I/physiology , Autonomic Nervous System/physiology , Brain/physiology , Peptide Fragments/physiology , Aging/physiology , Angiotensin I/deficiency , Animals , Baroreflex/physiology , Blood Pressure , Humans , Hypertension/etiology , Hypertension/genetics , MAP Kinase Signaling System , Medulla Oblongata/physiology , Peptide Fragments/deficiency , Phosphatidylinositol 3-Kinases/physiology
3.
Kidney Blood Press Res ; 33(6): 476-88, 2010.
Article in English | MEDLINE | ID: mdl-21071955

ABSTRACT

AIMS: the present study was performed to evaluate the effects of target disruption of the G-protein-coupled receptor Mas for angiotensin 1-7 [Ang(1-7)] in knockout mice on the course of two-kidney, one-clip (2K1C) Goldblatt hypertension. METHODS: knockout and wild-type mice underwent clipping of one renal artery. Blood pressure (BP) was monitored by radiotelemetry. The mice were either untreated or chronically treated with the superoxide (O(2)(-)) scavenger tempol (400 mg/l) or the inhibitor of NADPH oxidase apocynin (1 g/l) administered in drinking water. RESULTS: knockout mice responded to clipping by accelerated increases in BP and the final BP was significantly higher than that in wild-type mice. Chronic treatment with tempol or apocynin elicited similar antihypertensive effects in 2K1C/knockout as in 2K1C/wild-type mice. Acute nitric oxide synthase inhibition caused greater BP increases in 2K1C/wild-type than in 2K1C/knockout mice. CONCLUSION: our present findings support the notion that the angiotensin-converting enzyme 2-Ang(1-7)-Mas axis serves as an important endogenous physiological counterbalancing mechanism that partially attenuates the hypertensinogenic actions of the activated renin-angiotensin system. The impairment in this axis may contribute to the deterioration of the course of 2K1C Goldblatt hypertension.


Subject(s)
Angiotensin II/physiology , Angiotensin I/deficiency , Angiotensin I/genetics , Disease Progression , Hypertension, Renovascular/metabolism , Nitric Oxide/deficiency , Peptide Fragments/deficiency , Peptide Fragments/genetics , Proto-Oncogene Proteins/deficiency , Proto-Oncogene Proteins/genetics , Receptors, G-Protein-Coupled/deficiency , Receptors, G-Protein-Coupled/genetics , Animals , Blood Pressure/drug effects , Blood Pressure/physiology , Hypertension, Renovascular/genetics , Hypertension, Renovascular/pathology , Male , Mice , Mice, Knockout , Nitric Oxide/physiology , Proto-Oncogene Mas , Surgical Instruments , Vasomotor System/drug effects , Vasomotor System/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...